DiviTum TKa

SEK 122 million gives Biovica the power to scale up globally

Biovica has secured SEK 122 million through a capital raise to scale up sales. The core of the investment is DiviTum...

Intervju

Medicinteknik

Biovica's CEO: "Expects to become cash flow positive in mid-2025"

The Uppsala company Biovica has got off to a good start with the market launch...

Intervju

Video

Biovica makes rights issue to become cash flow positive

The doors to both the USA and Europe are open...

BioStock Investor Pitch: Biovica

The Uppsala company Biovica has closed a number of...

Video

Biovica CEO: "DiviTum TKa has had a good start in the US"

Biovica is in full swing with the launch of...

Intervju